DJIA 15,318.23 138.38 0.91%
NASDAQ 3,482.18 30.05 0.87%
S&P 500 1,651.81 12.77 0.78%
market minute promo

Myriad Genetics

NASDAQ: MYGN

26.44 -0.18 (-0.68%)

REAL-TIME: Last trade at

Extended Hours: $26.51 $0.07 (0.26%)
Quote as of (NASDAQ)


company name or ticker

Recent Quotes

MYGN $26.44 -0.68%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $26.50
Previous Close $26.62
Daily Range $25.97 - $26.89
52-Week Range $22.02 - $38.27
Market Cap $2.1B
P/E Ratio 16.96
Dividend (Yield) $0.00 (0.0%)
Volume 3,529,282
Average Daily Volume 2,554,846
Current FY EPS $1.66

Sector

Services

Industry

Diversified Services

Myriad Genetics (MYGN) Description

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products. Website: http://www.myriad.com/

News & Commentary

German Court Rules in Favor of MDT - Analyst Blog

Myriad: End to Legal Battle over Patents - Analyst Blog

Myriad Genetics Inc. (MYGN): Today's Featured Diversified Services Laggard

DaVita, Myriad RBM Announce Biomarker Research Collaboration

LIFE Continues Korean Expansion - Analyst Blog

Supreme Court Lets the Gene Out of the Bottle

Will this week's Supreme Court ruling on gene patents release some biotech magic?

Mid-Afternoon Market Update: Walter Energy Plummets as Oil Posts a Strong Rally

Mid-Afternoon Market Update: Walter Energy Plummets as Oil Posts a Strong Rally

Company News for June 14, 2013 - Corporate Summary

Why Myriad Genetics Shares Swooned Again

A Supreme Court ruling hangover and a flurry of analyst activity sends Myriad shares back under the covers.

See More MYGN News...

MYGN's Top Competitors

MYGN $26.44 (-0.68%)
Current stock: MYGN
AMGN $101.50 (2.44%)
Current stock: AMGN
GILD $51.94 (1.78%)
Current stock: GILD
BIIB $210.80 (1.47%)
Current stock: BIIB